Literature DB >> 34294714

CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells.

Yuzo Koda1,2, Toshiaki Teratani1, Po-Sung Chu1, Yuya Hagihara1, Yohei Mikami1, Yosuke Harada1, Hanako Tsujikawa3, Kentaro Miyamoto1, Takahiro Suzuki1, Nobuhito Taniki1, Tomohisa Sujino1, Michiie Sakamoto3, Takanori Kanai4,5, Nobuhiro Nakamoto6.   

Abstract

Non-alcoholic steatohepatitis (NASH) is a leading cause of chronic liver disease that can progress to liver fibrosis. Recent clinical advance suggests a reversibility of liver fibrosis, but the cellular and molecular mechanisms underlying NASH resolution remain unclarified. Here, using a murine diet-induced NASH and the subsequent resolution model, we demonstrate direct roles of CD8+ tissue-resident memory CD8+ T (CD8+ Trm) cells in resolving liver fibrosis. Single-cell transcriptome analysis and FACS analysis revealed CD69+CD103-CD8+ Trm cell enrichment in NASH resolution livers. The reduction of liver CD8+ Trm cells, maintained by tissue IL-15, significantly delayed fibrosis resolution, while adoptive transfer of these cells protected mice from fibrosis progression. During resolution, CD8+ Trm cells attracted hepatic stellate cells (HSCs) in a CCR5-dependent manner, and predisposed activated HSCs to FasL-Fas-mediated apoptosis. Histological assessment of patients with NASH revealed CD69+CD8+ Trm abundance in fibrotic areas, further supporting their roles in humans. These results highlight the undefined role of liver CD8+ Trm in fibrosis resolution.
© 2021. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34294714     DOI: 10.1038/s41467-021-24734-0

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  48 in total

Review 1.  Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.

Authors:  Anabela P Rolo; João S Teodoro; Carlos M Palmeira
Journal:  Free Radic Biol Med       Date:  2011-10-13       Impact factor: 7.376

Review 2.  The balancing act of the liver: tissue regeneration versus fibrosis.

Authors:  Lucía Cordero-Espinoza; Meritxell Huch
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

Review 3.  Mechanisms of hepatic stellate cell activation.

Authors:  Takuma Tsuchida; Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-10       Impact factor: 46.802

4.  Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease.

Authors:  Sahil Mittal; Hashem B El-Serag; Yvonne H Sada; Fasiha Kanwal; Zhigang Duan; Sarah Temple; Sarah B May; Jennifer R Kramer; Peter A Richardson; Jessica A Davila
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-18       Impact factor: 11.382

Review 5.  Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.

Authors:  Thomas G Cotter; Mary Rinella
Journal:  Gastroenterology       Date:  2020-02-13       Impact factor: 22.682

Review 6.  Molecular mediators of hepatic steatosis and liver injury.

Authors:  Jeffrey D Browning; Jay D Horton
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 7.  Nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Vincent W-S Wong; Valerio Nobili; Christopher P Day; Silvia Sookoian; Jacquelyn J Maher; Elisabetta Bugianesi; Claude B Sirlin; Brent A Neuschwander-Tetri; Mary E Rinella
Journal:  Nat Rev Dis Primers       Date:  2015-12-17       Impact factor: 52.329

Review 8.  Mechanisms of NAFLD development and therapeutic strategies.

Authors:  Scott L Friedman; Brent A Neuschwander-Tetri; Mary Rinella; Arun J Sanyal
Journal:  Nat Med       Date:  2018-07-02       Impact factor: 53.440

9.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

Review 10.  Adaptive immunity: an emerging player in the progression of NAFLD.

Authors:  Salvatore Sutti; Emanuele Albano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-10-11       Impact factor: 46.802

View more
  14 in total

Review 1.  Liver-resident memory T cells: life in lockdown.

Authors:  Laura J Pallett; Mala K Maini
Journal:  Semin Immunopathol       Date:  2022-04-28       Impact factor: 9.623

Review 2.  Hepatic Stellate Cell-Immune Interactions in NASH.

Authors:  James K Carter; Scott L Friedman
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

Review 3.  Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.

Authors:  Christy E Trussoni; Steven P O'Hara; Nicholas F LaRusso
Journal:  Semin Immunopathol       Date:  2022-02-17       Impact factor: 11.759

4.  Targeting tissue-resident memory CD8+ T cells in the kidney is a potential therapeutic strategy to ameliorate podocyte injury and glomerulosclerosis.

Authors:  Liang Li; Wei Tang; Yan Zhang; Meng Jia; Limei Wang; Quanxin Li; Qingsheng Han; Xiuping Peng; Yusheng Xie; Jichao Wu; Ziying Wang; Junhui Zhen; Xiaojie Wang; Min Liu; Yu Sun; Chun Zhang; Fan Yi
Journal:  Mol Ther       Date:  2022-05-05       Impact factor: 12.910

Review 5.  Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.

Authors:  Petra Hirsova; Adebowale O Bamidele; Haiguang Wang; Davide Povero; Xavier S Revelo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-28       Impact factor: 6.055

6.  Islet Lymphocytes Maintain a Stable Regulatory Phenotype Under Homeostatic Conditions and Metabolic Stress.

Authors:  Jennifer C Whitesell; Robin S Lindsay; Jessica G Olivas-Corral; Seth F Yannacone; Mary H Schoenbach; Erin D Lucas; Rachel S Friedman
Journal:  Front Immunol       Date:  2022-01-25       Impact factor: 7.561

Review 7.  T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease.

Authors:  Yoseph Asmelash Gebru; Haripriya Gupta; Hyeong Seop Kim; Jung A Eom; Goo Hyun Kwon; Eunju Park; Jin-Ju Jeong; Sung-Min Won; Satya Priya Sharma; Raja Ganesan; Dong Joon Kim; Ki Tae Suk
Journal:  Int J Mol Sci       Date:  2021-11-11       Impact factor: 5.923

8.  In mouse chronic pancreatitis CD25+FOXP3+ regulatory T cells control pancreatic fibrosis by suppression of the type 2 immune response.

Authors:  Juliane Glaubitz; Anika Wilden; Janine Golchert; Georg Homuth; Uwe Völker; Barbara M Bröker; Thomas Thiele; Markus M Lerch; Julia Mayerle; Ali A Aghdassi; Frank U Weiss; Matthias Sendler
Journal:  Nat Commun       Date:  2022-08-03       Impact factor: 17.694

9.  Lycorine Ameliorates Thioacetamide-Induced Hepatic Fibrosis in Rats: Emphasis on Antioxidant, Anti-Inflammatory, and STAT3 Inhibition Effects.

Authors:  Huda Mohammed Alkreathy; Ahmed Esmat
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-18

Review 10.  Diet and Gut Microbiota Interaction-Derived Metabolites and Intrahepatic Immune Response in NAFLD Development and Treatment.

Authors:  Ming Yang; Lea Khoukaz; Xiaoqiang Qi; Eric T Kimchi; Kevin F Staveley-O'Carroll; Guangfu Li
Journal:  Biomedicines       Date:  2021-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.